Breaking
Saturday, June 27, 2026

Mergers & Acquisitions News

🇺🇸 FDA

FDA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–12 of 18 articles

Medium impact NewsJun 18, 2026

Adial Pharmaceuticals Completes Azora Merger, Expands Ulcerative Colitis Pipeline

FDA · 3 min

Michael Rivera
High impact NewsJun 12, 2026

Socioeconomic status shapes children’s brain development, study finds

4 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

Takeda TYK2 drug tops Bristol Myers’ Sotyktu in psoriasis head-to-head test

psoriasis · 5 min

Dr. Sarah Mitchell
High impact NewsJun 11, 2026

AstraZeneca expands obesity push as it invests $125M in ultrasound medicine

FDA · obesity · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 8, 2026

Tillomed Laboratories update: pipeline, melphalan and next catalysts

oncology · 6 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

Sanofi completes Inhibrx acquisition for $1.7B

inflammation · 4 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Merck’s Harpoon acquisition deepens oncology pipeline ahead of Keytruda risk

oncology · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Puma Biotechnology Inducement Awards: Strategic Talent Moves Under Nasdaq Rule 5635(c)(4)

Nasdaq · 4 min

Dr. Sarah Mitchell
High impact NewsJun 4, 2026

Fierce Biotech Week 2026: Key Insights and Highlights

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

Vir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM

FDA · 7 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

Ten-Year-Old Cambridge Biotech Seeks Merger or Acquisition Amidst Market Pressures

FDA · sickle cell · 6 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Longeveron Stockholder Letter Outlines 2026 Strategy and Partnership Focus

FDA · 6 min

Dr. Sarah Mitchell